• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级保健临床实践中气道疾病的支气管炎异质性。

Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.

机构信息

Firestone Institute for Respiratory Health, St. Joseph's Healthcare & Department of Medicine, McMaster University, Hamilton, Ontario.

出版信息

Can Respir J. 2011 May-Jun;18(3):144-8. doi: 10.1155/2011/430317.

DOI:10.1155/2011/430317
PMID:21766077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3328881/
Abstract

BACKGROUND

Sputum cell counts have identified inflammatory subtypes of bronchitis in relatively small numbers of subjects with asthma, chronic obstructive pulmonary disease (COPD) and chronic cough in research studies. The prevalence of different subtypes of bronchitis in routine clinical practice, however, has not been reported.

OBJECTIVE

To examine the heterogeneity of bronchitis and its relationship to the severity of airflow obstruction.

METHODS

A retrospective cross-sectional survey based on a computerized database of spontaneous or induced sputum cell counts examined in a large university tertiary respiratory outpatient clinic.

RESULTS

The database contained 4232 consecutive sputum records from 2443 patients with chronic cough (39%), asthma (37%), asthma with COPD (9%), COPD (13%) and bronchiectasis (3%). Total and differential cell counts were obtained from 86% of successful sputum samples. Induced sputum provided more viable samples than spontaneous expectorate. Approximately one-third of patients with asthma and one-fifth of patients with COPD experience eosinophilic bronchitis. Asthmatic patients with moderate to severe airflow obstruction had a greater number of sputum eosinophils. There was a significantly higher number of total cell counts and percentage of neutrophils in the sputum of COPD patients with moderate and severe airflow obstruction than in those with mild airflow obstruction.

CONCLUSION

There is heterogeneity in the cellularity of sputum in various airway diseases. Patients with clinically stable airway diseases may have high sputum cell counts. During exacerbations, more patients may experience neutrophilic bronchitis. Severity of airflow obstruction is associated with eosinophilic bronchitis in patients with asthma, and neutrophilic bronchitis in patients with nonasthmatic COPD.

摘要

背景

在哮喘、慢性阻塞性肺疾病(COPD)和慢性咳嗽的研究中,痰细胞计数已经确定了支气管炎症的亚型,但在常规临床实践中,不同类型的支气管炎的患病率尚未报道。

目的

检查支气管炎的异质性及其与气流阻塞严重程度的关系。

方法

一项基于大型大学三级呼吸门诊中计算机化的自发性或诱导性痰细胞计数数据库的回顾性横断面调查。

结果

该数据库包含了 2443 名慢性咳嗽(39%)、哮喘(37%)、哮喘合并 COPD(9%)、COPD(13%)和支气管扩张症(3%)患者的 4232 份连续痰记录。86%的成功痰液样本中获得了总细胞计数和分类细胞计数。诱导痰比自发性咳痰提供了更多的可培养样本。大约三分之一的哮喘患者和五分之一的 COPD 患者经历嗜酸性粒细胞性支气管炎。中重度气流阻塞的哮喘患者痰中嗜酸性粒细胞数量较多。中重度气流阻塞的 COPD 患者的痰总细胞计数和中性粒细胞百分比明显高于轻度气流阻塞的患者。

结论

各种气道疾病的痰细胞成分存在异质性。患有临床稳定气道疾病的患者可能有高痰细胞计数。在恶化期间,更多的患者可能会经历中性粒细胞性支气管炎。哮喘患者的气流阻塞严重程度与嗜酸性粒细胞性支气管炎有关,非哮喘性 COPD 患者与中性粒细胞性支气管炎有关。

相似文献

1
Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.三级保健临床实践中气道疾病的支气管炎异质性。
Can Respir J. 2011 May-Jun;18(3):144-8. doi: 10.1155/2011/430317.
2
Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice.通过诱导痰细胞计数测定气道疾病的炎症成分:在临床实践中的应用。
J Bras Pneumol. 2008 Nov;34(11):913-21. doi: 10.1590/s1806-37132008001100005.
3
Airway inflammation and cellular stress in noneosinophilic atopic asthma.非嗜酸性粒细胞性特应性哮喘中的气道炎症与细胞应激
Chest. 2006 May;129(5):1194-202. doi: 10.1378/chest.129.5.1194.
4
Eosinophilic airway disorders.嗜酸性气道疾病
Semin Respir Crit Care Med. 2006 Apr;27(2):128-33. doi: 10.1055/s-2006-939515.
5
Clinical and biological factors associated with irreversible airway obstruction in adult asthma.成人哮喘中与不可逆气道阻塞相关的临床和生物学因素。
Respir Med. 2020 Dec;175:106202. doi: 10.1016/j.rmed.2020.106202. Epub 2020 Nov 10.
6
Persistent sputum cellularity and neutrophils may predict bronchiectasis.持续的痰液细胞增多和中性粒细胞可能预示着支气管扩张症。
Can Respir J. 2011 Jul-Aug;18(4):221-4. doi: 10.1155/2011/920465.
7
Changing Pattern of Sputum Cell Counts During Successive Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病连续加重期间痰液细胞计数的变化模式
COPD. 2015;12(6):628-35. doi: 10.3109/15412555.2015.1057808. Epub 2015 Aug 11.
8
Chronic cough: eosinophilic bronchitis without asthma.慢性咳嗽:无哮喘的嗜酸性粒细胞性支气管炎
Lancet. 1989 Jun 17;1(8651):1346-8. doi: 10.1016/s0140-6736(89)92801-8.
9
Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.痰液细胞计数:哮喘、慢性阻塞性肺疾病及哮喘-慢性阻塞性肺疾病重叠综合征鉴别中的生物标志物
Int J Chron Obstruct Pulmon Dis. 2017 Sep 11;12:2703-2710. doi: 10.2147/COPD.S142466. eCollection 2017.
10
Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.炎症标志物在支气管扩张试验阳性的稳定期慢性阻塞性肺疾病患者诱导痰中的应用。
Curr Med Sci. 2019 Aug;39(4):560-567. doi: 10.1007/s11596-019-2074-7. Epub 2019 Jul 25.

引用本文的文献

1
The success rate and safety of induced sputum is better than you think: give it a try!诱导痰的成功率和安全性比你想象的要好:试试看!
ERJ Open Res. 2025 May 6;11(3). doi: 10.1183/23120541.00871-2024. eCollection 2025 May.
2
Eosinophils and therapeutic responses to steroids and biologics in COPD: a complex relationship.嗜酸性粒细胞与慢性阻塞性肺疾病(COPD)中对类固醇和生物制剂的治疗反应:一种复杂的关系。
J Bras Pneumol. 2023 Dec 22;49(6):e20230360. doi: 10.36416/1806-3756/e20230360.
3
Non-eosinophilic asthma in nonsteroidal anti-inflammatory drug exacerbated respiratory disease.非甾体抗炎药加重的呼吸道疾病中的非嗜酸性粒细胞性哮喘。
Clin Transl Allergy. 2023 Mar;13(3):e12235. doi: 10.1002/clt2.12235.
4
Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways.细菌DNA会加剧白细胞介素-17暴露气道中的嗜中性粒细胞炎症。
ERJ Open Res. 2023 Jan 23;9(1). doi: 10.1183/23120541.00474-2022. eCollection 2023 Jan.
5
Current and emerging biologic therapies targeting eosinophilic disorders.针对嗜酸性粒细胞疾病的现有及新兴生物疗法。
World Allergy Organ J. 2022 Jul 31;15(8):100676. doi: 10.1016/j.waojou.2022.100676. eCollection 2022 Aug.
6
Underestimation of airway luminal eosinophilia by quantitative sputum cytometry.定量痰液细胞计数法对气道管腔嗜酸性粒细胞增多症的低估
Allergy Asthma Clin Immunol. 2021 Jul 5;17(1):63. doi: 10.1186/s13223-021-00567-w.
7
Asthma in the Precision Medicine Era: Biologics and Probiotics.精准医学时代的哮喘:生物制剂和益生菌。
Int J Mol Sci. 2021 Apr 26;22(9):4528. doi: 10.3390/ijms22094528.
8
Targeted therapy in eosinophilic chronic obstructive pulmonary disease.嗜酸性慢性阻塞性肺疾病的靶向治疗
ERJ Open Res. 2021 Apr 12;7(2). doi: 10.1183/23120541.00437-2020. eCollection 2021 Apr.
9
Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant.细胞质量对 COPD 痰液上清液中炎症生物标志物的影响。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 1;16:487-493. doi: 10.2147/COPD.S284938. eCollection 2021.
10
Neutrophils in asthma: the good, the bad and the bacteria.哮喘中的中性粒细胞:有益、有害与细菌
Thorax. 2021 Feb 25;76(8):835-44. doi: 10.1136/thoraxjnl-2020-215986.

本文引用的文献

1
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples.接受皮质类固醇治疗的哮喘患者痰液炎症细胞的变异性:一项使用多个样本的前瞻性研究。
J Allergy Clin Immunol. 2010 May;125(5):1161-1163.e4. doi: 10.1016/j.jaci.2010.02.005. Epub 2010 Apr 14.
2
Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study.难治性哮喘患者痰液嗜酸性粒细胞增多的一致性:一项5年随访研究
J Allergy Clin Immunol. 2009 Sep;124(3):615-7, 617.e1-2. doi: 10.1016/j.jaci.2009.06.029.
3
The definition and diagnosis of asthma.哮喘的定义与诊断。
Clin Exp Allergy. 2009 Nov;39(11):1652-8. doi: 10.1111/j.1365-2222.2009.03321.x. Epub 2009 Jul 20.
4
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.美泊利单抗用于治疗伴有痰液嗜酸性粒细胞增多的泼尼松依赖型哮喘。
N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.
5
Asthma management by monitoring sputum neutrophil count.通过监测痰液中性粒细胞计数进行哮喘管理。
Chest. 2008 Sep;134(3):628-630. doi: 10.1378/chest.08-0400.
6
Global strategy for asthma management and prevention: GINA executive summary.哮喘管理和预防全球战略:全球哮喘防治创议执行摘要
Eur Respir J. 2008 Jan;31(1):143-78. doi: 10.1183/09031936.00138707.
7
Changing pattern of sputum cell counts during successive exacerbations of airway disease.气道疾病连续发作期间痰液细胞计数的变化模式。
Respir Med. 2007 Oct;101(10):2217-20. doi: 10.1016/j.rmed.2007.05.010. Epub 2007 Jul 2.
8
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.慢性阻塞性肺疾病诊断、管理和预防全球策略:GOLD执行摘要
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
9
Asthma, COPD and bronchitis are just components of airway disease.哮喘、慢性阻塞性肺疾病和支气管炎只是气道疾病的组成部分。
Eur Respir J. 2006 Aug;28(2):264-7. doi: 10.1183/09031936.06.00056106.
10
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.通过监测痰液细胞计数确定哮喘治疗方案:对病情加重的影响
Eur Respir J. 2006 Mar;27(3):483-94. doi: 10.1183/09031936.06.00137704.